Opportunities in Human Embryonic Stem Cell (hESC)
Products - Trends and Forecasts to 2017

Improve product development decisions, target unmet market needs, and produce higher prospect-to-client conversion rates.

Industry Report, October 2013
Format: PDF; 158 Pages
 

TABLE OF CONTENTS

I. STRATEGIC OVERVIEW

II. ACCESS & AVAILABILITY OF hESC LINES
    A. NIH Registry Approved hESC Lines
    B. Sources of Additional Published hESC Lines
    C. Sources of Additional Unpublished hESC Lines

III. END-USER APPLICATIONS OF hESCs
    A. Basic Research
    B. Cellular Therapies
        1. Overview
        2. Characterization of Source hESCs for Cellular Therapy
        3. Promising Areas of hESC Cellular Therapy Research
            a. Heart Regeneration
            b. Pancreatic Islet Cell Replacement
            c. Neural Regeneration
    C. Tissue Engineering
    D. Toxicology Testing
        1. High-Value Opportunities
        2. Optimization & Validation of hESC Toxicology Assays

IV. PATENT ENVIRONMENT
    A. Landmark hESC Patents: WARF “Composition of Matter” Patents
        1. Background
        2. Licensing of WARF Patent Rights
        3. WARF Patent Exemption: Federal Rights to hESC Research
        4. U.S. WARF Patent Challenges
        5. Circumventing WARF Patent Rights Using Geographic Limitations
    B. Global Stem Cell Patent Landscape
    C. U.S. Patents of Importance
        1. Geron Corporation Patents
        2. Regents of the University of California Patents
        3. BresaGen, Inc. Patents
        4. Regeneron Pharmaceuticals, Inc.
        5. Vanderbuilt University Patents
    D. Worldwide Patents of Importance
        1. ES Cell International PTE Ltd. Patents (Singapore)
        2. DNAVEC Research Inc. Patents (Japan)
        3. University of Edinburgh Patents (Scotland)
    E. Summary of the hESC Intellectual Property Landscape

V. MARKET TREND ANALYSIS - FUTURE GROWTH PROJECTIONS
    A. Scientific Publication Analysis
        1. Historical Analysis (Trailing 10 Years)
        2. Future Growth Predictions (5-Year Forecasts, 2013-17)
        3. Breakdown of ESC Research by Species
    B. Grant Analysis
    C. Patent Analysis

VI. MARKET SIZE
    A. Definitions
    B. Experimental Approach
    C. Annual Market Size - Human Embryonic Stem Cell Products

VII. MARKET CHARACTERIZATION
    A. Key Research Applications
        1. Size of Market Segments
        2. Trend Data
    B.  Geographical Breakdown (Country-by-Country Breakdown)

VIII. hESC RESEARCH SUPPLY COMPETITORS
    A. Cellartis AB
    B. Vitrolife
    C. Tataa Biocenter
    D. Invitrogen
    E. Stem Cell Technologies
    F. BD Biosciences
    G. Chemicon
    H. R&D Systems
    I. SA Biosciences
    J. Thermo Scientific
    K. Australian Stem Cell Centre

IX. SPECIALTY PHARMACEUTICAL COMPANIES DEVELOPING hESC THERAPIES
    A. Geron
    B. Novocell
    C. Cell Cure Neurosciences Ltd
    D. Cell Dynamics International
    E. Advanced Cell Technology

X. TOXICOLOGY TESTING LEGISLATION
    A. European Union Ban of Animal-Testing for Cosmetic Development (2013)
    B. Responses to the European Ban on Animal Testing for Cosmetic Development
        1. Overview
        2. Skin Irritation
        3. Eye Irritation
        4. Skin Sensitisation
        5. Mutagenicity/Genotoxicity
        6. Reproductive Toxicity
    C. EU Legislation Regarding Animal-Based Testing for Drug Discovery

XI. STRATEGIC PRODUCT & TECHNOLOGY DEVELOPMENT
    A. Product Categories
    B. Product Ideas & Suggestions
        1. Areas of Underdeveloped Competition
        2. Mouse ESC Products
        3. iPS Cells Products
        4. Non-animal-derived Culture Reagents for hESCs
        5. Strategic Collaborations
        6. Products for Generating Pure ESC populations
        7. hESC Toxicity Assay Kit

XII. STRATEGIES FOR ACCESSING THE MARKETPLACE
    A. Top Research Institutions Performing hESC Research
        1. Academic Labs
        2. Private Labs
        3. Government Labs
        4. International Labs
    B. Events of Interest - hESC Conferences & Symposiums

XIII. SCIENTIST PANEL: DETAILED END-USER SURVEY
    A. Survey Overview
    B. Characterization of Market Survey Respondents
        1. Geographic Distribution of Respondents
        2. Respondent Breakdown by Industry Affiliation
        3. Breakdown of Respondents by Duration of iPSC Research Activity
    C. Survey Findings
        1. General Scope
        2. Comparison of Providers / Brand Preferences
        3. Marketing Assessment
    D. Terms Used in Online Product Search

XIV. CONCLUSIONS

APPENDIX

Human Embryonic Stem Cell Research Centers & Contact Information



Additional Product Details

View Overview

"Test-Drive" The Product For Yourself

Free Product Sample


PURCHASE OPTIONS

Once your order is placed, you will be sent a download link for your document(s). If you are claiming a hard-copy version, it will be delivered by postal mail. For your convenience, multiple license formats are available. All major international currencies accepted.

1. Claim by Secure Online Checkout:


Buy Now!

2. Claim by Purchase Form:
Or, complete this Purchase Form to claim by credit card, check, or bank transfer.

To request a quote, please use the Live Chat or call us at 703.859.7617.




(Phone) 703-859-7617 info@bioinformant.com (Fax) 614-352-2369

Copyright © 2014 BioInformant Worldwide, L.L.C. All rights reserved.

Home | Company | Our Clients | Contact Us


60-Day Money Back Guarantee:
All BioInformant products come with a 100% Money Back Guarantee. If the strategies and tools aren't helpful to you - we'll cheerfully refund your money, and you can keep the product.